Literature DB >> 6150304

Increase in prevalence of anti-HTLV-III in haemophiliacs.

L G Gürtler, D Wernicke, J Eberle, G Zoulek, F Deinhardt, W Schramm.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6150304     DOI： 10.1016/s0140-6736(84)92823-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Seroepidemiology of HTLV-III (LAV) in the Federal Republic of Germany.

Authors:  G Hunsmann; J Schneider; H Bayer; R Kurth; A Werner; H D Brede; V Erfle; W Mellert; H R Brodt; L Bergmann
Journal:  Klin Wochenschr       Date:  1985-03-01

2.  [AIDS and HTLV-III in West Germany: the status February 1985].

Authors:  R Hehlmann; V Erfle; G Hunsmann; R Kurth
Journal:  Klin Wochenschr       Date:  1985-05-02

Review 3.  The natural history of human T lymphotropic virus-III infection: the cause of AIDS.

Authors:  M Melbye
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

4.  Investigating the presence of HIV sequences and the distribution of virological markers in hemophiliacs and their sexual partners.

Authors:  M da S Cardoso; S Epple; K Koerner; B Kubanek; D Ellbrück; E Seifried
Journal:  Ann Hematol       Date:  1991-12       Impact factor: 3.673

Review 5.  AIDS: a problem for intensive care.

Authors:  R A Banks; K J Lindley; A L Pozniak
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

6.  Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.

Authors:  P N Fultz; H M McClure; R B Swenson; C R McGrath; A Brodie; J P Getchell; F C Jensen; D C Anderson; J R Broderson; D P Francis
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

7.  Prevalence of antibodies to hepatitis C virus (HCV) in haemophiliacs.

Authors:  W Schramm; M Roggendorf; F Rommel; R Kammerer; H Pohlmann; R Rasshofer; L Gürtler; F Deinhardt
Journal:  Blut       Date:  1989-10

8.  Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemophiliacs and other patients chronically substituted with blood products.

Authors:  V Erfle; R Hehlmann; W Mellert; F D Goebel; H Rasokat; E Lechler; P Hellstern; M Köhler; E Seifried; H Heimpel
Journal:  Blut       Date:  1985-10

9.  Epidemiological evidence that HTLV-III is the AIDS agent.

Authors:  J J Goedert; R C Gallo
Journal:  Eur J Epidemiol       Date:  1985-09       Impact factor: 8.082

Review 10.  Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU).

Authors:  R T D'Aquila; A B Williams
Journal:  Yale J Biol Med       Date:  1987 Nov-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.